Leona Holmberg

Associate Professor, Department of Medicine and Oncology
University of Washington

Education:

BA, Harvard University
M.D., University of Miami, School of Medicine
Ph.D., Harvard University

Research Focus:

Relapse remains a major issue following an autologous transplant. Relapses result from either the infusion of contaminating tumor cells in the stem cell product and/or from the incomplete eradication of endogenous malignant cells by the transplant conditioning regimens. Directly following an autologous transplant, the immune system is relatively incompetent and this immune incompetence may contribute to the high relapse rates seen after autologous transplantation.

My clinical research interests have focused on trying to augment the immune system after an autologous transplant. A number of clinical trials using different approaches have been developed. Treating with immunological and non-immunological therapies posttransplant can possibly change the time to relapse and prolong survival.

Clinical Expertise:

  • Medical Oncology
  • Bone Marrow Transplantation
  • Immunotherapy
  • Transplantation Immunology


file

Contact Information

Phone
(206) 667-6447
Fax
(206) 667-4937
Email
Additional contact

Mail Stop: D5-390

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.